About this document
Mirabegron in Overactive Bladder Management by Miriam Robles is a document available to read on EtoBox.
Mirabegron is a first-in-class b3-adrenoceptor agonist approved for the treatment of overactive bladder (OAB) syndrome, showing efficacy in reducing micturition frequency, urgency, and incontinence, while improving health-related quality of life. Clinical trials indicate that mirabegron is generally well tolerated, with fewer side effects compared to traditional antimuscarinics, and its benefits are sustained over long-term use. However, caution is advised in patients with certain health conditions, and fur
- Author
- Miriam Robles
- Language
- EN